Evidence map›Paper›PMID 29188863›Full record

Trial reportThe journal of nutrition, health & aging2017

Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia.

C Hooper, P De Souto Barreto, N Coley, E Caussé, P Payoux, A S Salabert, M Cesari, S Andrieu, G-L Bowman, M Weiner and 1 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The journal of nutrition, health & aging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01953705 (Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01953705 phase2unknown statusnot on this map

Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline

TypeinterventionalSponsorOregon Health and Science UniversityRan2014 to 2021Enrolled102ConditionsAge Related Cognitive Decline, Alzheimer's Disease, Vascular Dementia, Endothelial DysfunctionArmsOmega 3 PUFA, Placebo
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

C HooperClaudie Hooper, Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France, claudie28@yahoo.com, Tel : +33 (5) 61 77 64 25; Fax : +33 (5) 61 77 64 75.
P De Souto Barreto
N Coley
E Caussé
P Payoux
A S Salabert
M Cesari
S Andrieu
G-L Bowman
M Weiner
B Vellas
Université Toulouse III - Paul Sabatier · FRCentre Hospitalier Universitaire de Toulouse · FRInserm · FRHôpital Purpan · FROregon Health & Science University · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesElevated total plasma homocysteine is a risk factor for Alzheimer's disease (AD) and there is some evidence that omega-3 polyunsaturated fatty acids (n-3 PUFAs) can modulate the effects of homocysteine-lowering B vitamins on AD related pathologies. Hence we investigated the relationship between total plasma homocysteine and cortical β-amyloid (Aβ) in older adults at risk of dementia. The role of erythrocyte membrane n-3 PUFAs (omega 3 index) on this relationship was also explored.

designThis is a cross-sectional study using data from the Multidomain Alzheimer Preventive Trial (MAPT); a randomised controlled trial.

settingFrench community dwellers aged 70 or over reporting subjective memory complaints, but free from a diagnosis of clinical dementia.

participantsIndividuals were from the MAPT trial (n = 177) with data on total plasma homocysteine at baseline and cortical Aβ load. MEASUREMENTS: Cortical-to-cerebellar standard uptake value ratios were assessed using [18F] florbetapir positron emission tomography (PET). Total baseline plasma homocysteine was measured using an enzymatic cycling assay. Baseline omega 3 index was measured using gas chromatography. Cross-sectional associations were explored using adjusted multiple linear regression models.

resultsWe found that total baseline plasma homocysteine was not significantly associated with cortical Aβ as demonstrated using multiple linear regression models adjusted for age, sex, education, cognitive status, time interval between baseline and PET-scan, omega-3 index, MAPT group allocation and Apolipoprotein E ε4 status (B-coefficient -0.001, 95 % CI: -0.008,0.006, p = 0.838). Exploratory analysis showed that homocysteine was however significantly associated with cortical Aβ in subjects with low baseline omega-3 index (< 4.72 %) after adjustment for Apolipoprotein E ε4 status (B-coefficient 0.041, 95 % CI: 0.017,0.066, p = 0.005, n = 10), but not in subjects with a high baseline omega-3 index (B-coefficient -0.010, 95 % CI: -0.023,0.003, p = 0.132, n = 66).

conclusionsThe role of n-3 PUFAs on the relationship between homocysteine and cerebral Aβ warrants further investigation.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesCross-Sectional StudiesDementiaFatty Acids, Omega-3FemaleHomocysteineHumansMaleRisk FactorsAmyloid beta-PeptidesFatty Acids, Omega-3HomocysteinedementiaHomocysteineomega-3 polyunsaturated fatty acidsβ-amyloid

Identifiers

PMID29188863
PMCPMC12880028
OpenAlexW2766003087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.